Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder

NCT07330648 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

216

Enrollment

OTHER

Sponsor class

Conditions

Generalized Anxiety Disorder

Interventions

DRUG: Crisugabalin 20mg bid
DRUG: Venlafaxine-XR 75mg bid
DRUG: Crisugabalin capsules mimic 0mg/capsule bid

Sponsor

Anhui Medical University